Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.34 +0.52 (+13.74%)
As of: Oct 21, 2026 · 1:19 PM EDT

Adial Pharmaceuticals (ADIL) Receivables - Net (2024 - 2025)

Updated

Adial Pharmaceuticals (ADIL) reported Receivables - Net of $41,758 for Q4 2025, down 25.5% from $56,020 a year earlier.

Analysis

Adial Pharmaceuticals (ADIL) Receivables - Net (2024 - 2025) Analysis & Trends

  • By year, Receivables - Net came in at $56,020 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.96 Bn 1,103.55 Bn 19.71 Bn
2 Johnson & Johnson 616.51 Bn 535.04 Bn 17.26 Bn
3 AbbVie 501.10 Bn 474.21 Bn 12.70 Bn
4 Merck 367.09 Bn 321.47 Bn 12.21 Bn
5 Novartis Ag 298.10 Bn 262.09 Bn 11.24 Bn
6 Astrazeneca 261.72 Bn 235.40 Bn 12.86 Bn
7 Amgen 235.73 Bn 191.13 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn
10 Adial Pharmaceuticals 20.38 Mn -23.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 41,758.00
Dec 31, 2024 56,020.00
API Access

Adial Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=ADIL&period=max&api_key=YOUR_API_KEY